Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	STESteris	ZBHZimmer Biomet	DXCMDexcom
Snapshot
Price	$209.01	$93.67	$89.89
Market cap	$21.27B	$17.28B	$27.49B
Valuation
P/E	26.1x	23.8x	37.6x
Forward P/E	20.4x	27.9x	26.9x
Growth
Revenue growth	8.7%	9.2%	16.1%
EPS growth	27.9%	-14.6%	77.5%
Profitability
Net margin	13.2%	9.1%	19.3%
ROE	11.1%	6.0%	33.8%
Balance sheet & cash
Debt / equity	0.27x	0.59x	0.47x
Free cash flow yield	5.4%	7.5%	1.8%
Dividend yield	1.2%	1.0%	—
Verdict
Investment rating	Favorable· 59	Neutral· 50	Favorable· 70

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	STEtoday $209	ZBHtoday $94	DXCMtoday $90
2027	$200.57 – $294.17+41% CAGR	$71.66 – $105.10+12% CAGR	$119.63 – $175.46+95% CAGR
2028	$256.63 – $376.39+34% CAGR	$73.09 – $107.20+7% CAGR	$212.29 – $311.36+86% CAGR
2029	$328.36 – $481.59+32% CAGR	$74.55 – $109.34+5% CAGR	$376.70 – $552.50+83% CAGR
2030	$420.14 – $616.20+31% CAGR	$76.04 – $111.53+4% CAGR	$668.46 – $980.41+82% CAGR
2031	$537.56 – $788.43+30% CAGR	$77.56 – $113.76+4% CAGR	$1,186.19 – $1,739.74+81% CAGR
5-yr CAGR	20.8% – 30.4%	-3.7% – 4.0%	67.5% – 80.9%